Company news
Sinovac Biotech, Ltd. (NASDAQ:SVA) news
Sinovac Biotech, Ltd. news releases on 6ix. Latest, Aug 17, 2026: SINOVAC Reports Unaudited First Half of 2026 Financial Results
Press releases & updates
SINOVAC Reports Unaudited First Half of 2026 Financial Results
August 17, 2026
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements
June 15, 2026
SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F
June 5, 2026
Sinovac Biotech : Annual Report for Fiscal Year Ending December 31, 2025 (Form 20-F)
June 5, 2026
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report
May 29, 2026
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
May 21, 2026
SINOVAC Reports Unaudited First Half of 2025 Financial Results
May 8, 2026
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024
April 29, 2026
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
January 21, 2026
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
January 3, 2026
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
January 3, 2026
Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
December 16, 2025
SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
November 17, 2025
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
November 11, 2025
/C O R R E C T I O N -- Heng Ren Partners/
November 11, 2025
SINOVAC Announces Appointment of Independent Auditor
October 23, 2025
SINOVAC Board Sets the Record Straight on July 8 Special Meeting of Shareholders
July 10, 2025
Newly Elected Directors of Sinovac Hold the First Board Meeting
July 9, 2025
SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former Board
July 8, 2025
SINOVAC Board of Directors Provides Update on Status of US$55.00 Special Cash Dividend Payment
July 8, 2025
SINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE Shares
July 8, 2025
Final Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card "AGAINST" Misguided Proposals 1 and 2
July 7, 2025
Federal Court in Massachusetts Denies Vivo Capital’s Petition for Relief on SINOVAC
July 7, 2025
Final Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card “AGAINST” Misguided Proposals 1 and 2
July 6, 2025
Leading Independent Proxy Advisory Firm ISS Joins Glass Lewis in Recommending Shareholders Vote to Keep the Current SINOVAC Board in Place
July 2, 2025
United States District Court of Massachusetts Bars Activist 1Globe Capital and Jiaqiang Li From Making Further Materially Misleading Statements Regarding Sinovac
July 1, 2025
Leading Independent Proxy Advisory Firm Glass Lewis Recommends SINOVAC Shareholders Vote to Keep the Current Board in Place
July 1, 2025
SINOVAC Board of Directors Urges Shareholders to Vote the WHITE Proxy Card “AGAINST” the Misguided Proposals to Remove SINOVAC’s Current Board
June 29, 2025
SINOVAC Board of Directors Prevails Against Advantech/Prime’s Lawsuit in Hong Kong
June 26, 2025
SINOVAC Board of Directors Files Investor Presentation Outlining Decisive Actions to Protect Shareholder Interests
June 23, 2025
SINOVAC Board of Directors Prevails Against Advantech/Prime’s New York Lawsuit
June 19, 2025
SINOVAC Board of Directors Files Definitive Proxy Materials
June 17, 2025
SINOVAC Announces New Board Member
June 17, 2025
SINOVAC Board of Directors Provides Update on Special Dividend Payment and Commitment to Delivering Value to All Shareholders
June 16, 2025
SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success’ New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders
June 15, 2025
SINOVAC’s Board of Directors Issues a Letter to Shareholders Outlining Clear Pathway to Restore Fairness and Deliver Value to All Shareholders
June 11, 2025
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2024 Annual Report
May 21, 2025
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend
April 29, 2025
SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital
April 28, 2025
SINOVAC Management Statement Regarding Auditor Resignation
April 21, 2025
SINOVAC Announces Decision to Declare Cash Dividend
March 31, 2025
SINOVAC Announces New Board Member and Chairman of the Audit Committee
March 27, 2025
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
February 27, 2025
SINOVAC Issues Statement Regarding Privy Council Judgment
January 15, 2025
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
December 15, 2024
SINOVAC Reports Unaudited First Half of 2024 Financial Results
August 15, 2024
SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F
April 28, 2024
Sinovac Amends Shareholder Rights Plan
February 20, 2024
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
January 17, 2024
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
September 10, 2023